Tournicare ARMA Automatic Blood Pressure Monitor (ARMA-08)
Tournicare Pty, Ltd. · Decision date Jun 15, 2026
What did the FDA decide?
FDA records K253059 as a 510(k) premarket notification, with a decision dated Jun 15, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Jun 15, 2026
Regulatory record facts
- Identifier
- K253059
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Tournicare Pty, Ltd.
- Product code
- DXN
- Decision code
- SESE
- Decision date
- Jun 15, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, Measurement, Blood-Pressure, Non-Invasive.
- Applicant
- Tournicare Pty, Ltd.
- Product code
- DXN
- FDA device class
- 2
FDA decision timeline
K253059 received
Application receipt date recorded by FDA.
K253059 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code DXN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. | 510(k) clearance | Oct 28, 2026 | FDA | |
| Shenzhen Brav Electronic Technologies Co., Ltd. | 510(k) clearance | Oct 1, 2026 | FDA | |
| OMRON Healthcare, Inc. | 510(k) clearance | Sep 10, 2026 | FDA | |
| Happy Health, Inc. | 510(k) clearance | Sep 3, 2026 | FDA | |
| Honsun (Nantong) Co., Ltd. | 510(k) clearance | Aug 31, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Tournicare Pty, Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Balwyn
Sources and methodology
- Original FDA record: K253059
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

